Skip to content

Clinical trials

Mastocytosis, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mastocytosis, Systemic Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20071
20082
20091
20131
20141
20153
20161
20181
20192
20204
20212
20222
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting4
Terminated4
Active, not recruiting3
Not yet recruiting1
Available1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation8
Cogent Biosciences, Inc.3
Jason Robert Gotlib3
M.D. Anderson Cancer Center3
National Institute of Allergy and Infectious Diseases (NIAID)3
Mayo Clinic2
Novartis Pharmaceuticals2
AB Science1
Adelphi Values LLC1
City of Hope Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mastocytosis, Systemic32
Leukemia, Mast-Cell15
Mastocytosis8
Leukemia4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Leukemia, Myeloid, Acute3
Blastic Plasmacytoid Dendritic Cell Neoplasm2
Hematologic Diseases2
Hematologic Neoplasms2
Hypersensitivity2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.